The Cooper Companies, Inc. (COO) witnessed a decline in its stock price during the current trading session, with the price dropping to $63.36, marking a decrease of 98 cents (-1.52%) compared to the previous close at $64.34. Trading volume stood at $956,704, representing a 47.77% increase relative to the average.
COO has experienced a six-day streak of negative price behavior, resulting in a total absolute change of $-6.7 (-9.56%). The streak started at a price of $70.06.
In its latest quarterly earnings report on Wednesday, March 4th, COO reported an earnings per share of 1.1, surpassing the consensus estimate of 1.03.
With a forward dividend yield of 0.189% and a dividend per share of 3 cents, COO continues to provide returns to its investors.
COO's cash flow statement indicates a free cash flow of $158.7 million, with notable operating cash flow of $260.90 million and a net change in cash of $14.3 million.
The company reported a revenue of $1 billion, resulting in a net income of $130.8 million and earnings per share of 66 cents.
Key ratios for COO include a net profit margin of 12.77%, return on equity of 1.56, and a price to earnings ratio of 30.6.
COO's balance sheet shows total assets of $12.42 billion, total liabilities of $4 billion, and net debt of $2.37 billion.
This comprehensive overview provides insight into COO's current financial status and performance in the market.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.